0001501187-16-000003.txt : 20160607 0001501187-16-000003.hdr.sgml : 20160607 20160606191628 ACCESSION NUMBER: 0001501187-16-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160607 DATE AS OF CHANGE: 20160606 EFFECTIVENESS DATE: 20160607 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stratos Genomics Inc. CENTRAL INDEX KEY: 0001501187 IRS NUMBER: 262836047 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-147647 FILM NUMBER: 161699714 BUSINESS ADDRESS: STREET 1: WORLD TRADE CENTER EAST STREET 2: 2211 ELLIOTT AVENUE CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-448-1388 MAIL ADDRESS: STREET 1: WORLD TRADE CENTER EAST STREET 2: 2211 ELLIOTT AVENUE CITY: SEATTLE STATE: WA ZIP: 98121 D/A 1 primary_doc.xml X0707 D/A LIVE 0001501187 Stratos Genomics Inc. WORLD TRADE CENTER EAST 2211 ELLIOTT AVENUE SEATTLE WA WASHINGTON 98121 206-448-7961 WASHINGTON None None Corporation true Mark Kokoris World Trade Center East 2211 Elliott Avenue Seattle WA WASHINGTON 98121 Executive Officer Director Heiner Dreismann World Trade Center East 2211 Elliott Avenue Seattle WA WASHINGTON 98121 Director Lee Huntsman World Trade Center East 2211 Elliott Avenue Seattle WA WASHINGTON 98121 Executive Officer Director Harold Kawaguchi World Trade Center East 2211 Elliott Avenue Seattle WA WASHINGTON 98121 Director Allan Stephan World Trade Center East 2211 Elliott Avenue Seattle WA WASHINGTON 98121 Director Robert McRuer World Trade Center East 2211 Elliott Avenue Seattle WA WASHINGTON 98121 Executive Officer Director Stephen Rose World Trade Center East 2211 Elliott Avenue Seattle WA WASHINGTON 98121 Director Biotechnology Decline to Disclose 06b true 0001501187-10-000001 2010-07-30 false true true false 0 Dr. Heiner Dreismann None None None 2401 Elliot Avenue Fifth Floor Seattle WA WASHINGTON 98121 WA WASHINGTON false 4520502 4520502 0 Total Offering Amount includes (i) principal and accrued interest on previously issued convertible notes that converted into equity; (ii) aggregate exercise price of warrants issued upon conversion of the notes; and (iii) warrants issued as finders' fees. false 19 0 29999 true Finders' Fees, represents a warrant to purchase common shares issued to the placement agent pursuant to the terms of the subject financing. 0 true false Stratos Genomics Inc. /s/ Mark Kokoris Mark Kokoris President and CEO 2016-06-06